(redirected from vulvovaginal candidiasis)
Also found in: Thesaurus, Medical, Encyclopedia.


Infection with a fungus of the genus Candida, especially C. albicans, that usually occurs in the skin and mucous membranes of the mouth, respiratory tract, or vagina but may invade the bloodstream, especially in immunocompromised individuals. Also called candidosis, moniliasis.


(Medicine) another name for thrush21a


(ˌkæn dɪˈdaɪ ə sɪs)

n., pl. -ses (-ˌsiz)
any of a variety of infections caused by fungi of the genus Candida, occurring most often in the mouth, respiratory tract, or vagina. Compare thrush 2 (def. 1).
[1945–50; < New Latin Candid(a) + -iasis]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.candidiasis - an infection caused by fungi of the genus Monilia or Candida (especially Candida albicans)candidiasis - an infection caused by fungi of the genus Monilia or Candida (especially Candida albicans)
Candida albicans, Monilia albicans - a parasitic fungus that can infect the mouth or the skin or the intestines or the vagina
fungal infection, mycosis - an inflammatory condition caused by a fungus
thrush - candidiasis of the oral cavity; seen mostly in infants or debilitated adults
vaginitis - inflammation of the vagina (usually associated with candidiasis)


n candidiasis f, infección f por hongos or levaduras
References in periodicals archive ?
In childbearing age, BV and vulvovaginal candidiasis are the most frequently vulvovaginitis in gynaecology and affect women physiologically, physically, socially, economically and in terms of reproductive health.
This pathological condition is known as vulvovaginal candidiasis (VVC); 75% of women are reported to experience at least one episode of VVC in their lifetime.
Treatment of chronic recurrent vulvovaginal candidiasis with fluconazole (fungolon--Actavis).
In another randomized, double-blind, placebo controlled trial, women with vulvovaginal candidiasis received a standard dose of fluconazole plus probiotics (L.
Since its introduction in 1990 as a prophylactic antifungal agent after bone marrow transplantation, fluconazole (Diflucan) has become established as the dominant therapy for vulvovaginal candidiasis (WC) worldwide.
About five percent of women with vaginal yeast infections develop recurrent vulvovaginal candidiasis (RVVC), which is defined as four or more symptomatic vaginal yeast infections in a one-year period.
Global Markets Direct's, 'Vulvovaginal Candidiasis - Pipeline Review, H1 2012', provides an overview of the Vulvovaginal Candidiasis therapeutic pipeline.
M2 PHARMA-February 12, 2015-Viamet Launches Phase 2b Study of Fungal Inhibitor in Recurrent Vulvovaginal Candidiasis
INTRODUCTION: Vulvovaginal candidiasis (VVC) or Candida vaginitis is a common fungal infection among adult women during reproductive ages.
Fourteen studies, including 2 randomized clinical trials, 9 case series, and 4 case reports were included in this review of the clinical evidence utilizing intravaginal boric acid for vulvovaginal candidiasis.
290-005 is aimed to assess MGCD290 in combination with fluconazole against only fluconazole in vulvovaginal candidiasis patients.